Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Dec 30, 2021 |
signed chap.803 |
Dec 17, 2021 |
delivered to governor |
Jun 03, 2021 |
returned to assembly passed senate 3rd reading cal.904 substituted for s2966a |
May 24, 2021 |
referred to finance delivered to senate passed assembly ordered to third reading rules cal.68 rules report cal.68 reported |
May 19, 2021 |
reported referred to rules |
Apr 19, 2021 |
print number 336a |
Apr 19, 2021 |
amend and recommit to ways and means |
Feb 09, 2021 |
reported referred to ways and means |
Jan 06, 2021 |
referred to health |
Assembly Bill A336
Signed By Governor2021-2022 Legislative Session
Sponsored By
BRAUNSTEIN
Archive: Last Bill Status - Signed by Governor
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Votes
Bill Amendments
co-Sponsors
Jeffrey Dinowitz
Steven Otis
Steven Cymbrowitz
Jeffrion Aubry
multi-Sponsors
David McDonough
2021-A336 - Details
2021-A336 - Summary
Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in 90 morphine milligram equivalents or higher per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.
2021-A336 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 336 2021-2022 Regular Sessions I N A S S E M B L Y (PREFILED) January 6, 2021 ___________ Introduced by M. of A. BRAUNSTEIN, DINOWITZ, OTIS, CYMBROWITZ, AUBRY, L. ROSENTHAL, FERNANDEZ, STERN, HEVESI, HUNTER, JOYNER, PERRY, RAMOS -- Multi-Sponsored by -- M. of A. McDONOUGH -- read once and referred to the Committee on Health AN ACT to amend the public health law, in relation to prescribing an opioid antagonist with a patient's first opioid prescription in a given year THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 3309 of the public health law is amended by adding a new subdivision 7 to read as follows: 7. WITH THE FIRST PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF EACH YEAR FOR USE IN A SETTING OTHER THAN A GENERAL HOSPITAL OR NURSING HOME UNDER ARTICLE TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER ARTI- CLE THIRTY-ONE OF THE MENTAL HYGIENE LAW, OR WHEN A PRACTITIONER IS PRESCRIBING A CONTROLLED SUBSTANCE TO A PATIENT UNDER THE CARE OF HOSPICE AS DEFINED BY SECTION FOUR THOUSAND TWO OF THIS CHAPTER, THE PRESCRIBER SHALL PRESCRIBE AN OPIOID ANTAGONIST WHEN ANY OF THE FOLLOW- ING RISK FACTORS ARE PRESENT: (A) A HISTORY OF SUBSTANCE USE DISORDER; (B) HIGH DOSE OR CUMULATIVE PRESCRIPTIONS THAT RESULT IN OVER FIFTY MORPHINE MILLIGRAM EQUIVALENTS PER DAY; (C) CONCURRENT USE OF OPIOIDS AND BENZODIAZEPINE OR NONBENZODIAZEPINE SEDATIVE HYPNOTICS. § 2. This act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addition, amend- ment and/or repeal of any rule or regulation necessary for the implemen- tation of this act on its effective date are authorized to be made and completed by the commissioner of health on or before such effective date. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD03417-01-1
co-Sponsors
Jeffrey Dinowitz
Steven Otis
Steven Cymbrowitz
Jeffrion Aubry
multi-Sponsors
David McDonough
2021-A336A (ACTIVE) - Details
2021-A336A (ACTIVE) - Summary
Provides that with the first opioid prescription of each year for use in a setting other than a general hospital or nursing home under article twenty-eight of this chapter or facility under article thirty-one of the mental hygiene law, or when a practitioner is prescribing a controlled substance to a patient under the care of hospice, the prescriber shall prescribe an opioid antagonist when any of the following risk factors are present: a history of substance abuse disorder; high dose or cumulative prescriptions that result in 90 morphine milligram equivalents or higher per day; concurrent use of opioids and benzodiazepine or nonbenzodiazepine sedative hypnotics.
2021-A336A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 336--A 2021-2022 Regular Sessions I N A S S E M B L Y (PREFILED) January 6, 2021 ___________ Introduced by M. of A. BRAUNSTEIN, DINOWITZ, OTIS, CYMBROWITZ, AUBRY, L. ROSENTHAL, FERNANDEZ, STERN, HEVESI, HUNTER, JOYNER, PERRY, RAMOS, STECK, BARRON, McDONALD -- Multi-Sponsored by -- M. of A. McDONOUGH -- read once and referred to the Committee on Health -- reported and referred to the Committee on Ways and Means -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the public health law, in relation to prescribing an opioid antagonist with a patient's first opioid prescription in a given year THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Section 3309 of the public health law is amended by adding a new subdivision 7 to read as follows: 7. WITH THE FIRST PRESCRIPTION TO A PARTICULAR PATIENT OF AN OPIOID OF EACH YEAR FOR USE IN A SETTING OTHER THAN A GENERAL HOSPITAL OR NURSING HOME UNDER ARTICLE TWENTY-EIGHT OF THIS CHAPTER OR FACILITY UNDER ARTI- CLE THIRTY-ONE OF THE MENTAL HYGIENE LAW, OR WHEN A PRACTITIONER IS PRESCRIBING A CONTROLLED SUBSTANCE TO A PATIENT UNDER THE CARE OF HOSPICE AS DEFINED BY SECTION FOUR THOUSAND TWO OF THIS CHAPTER, THE PRESCRIBER SHALL PRESCRIBE AN OPIOID ANTAGONIST WHEN ANY OF THE FOLLOW- ING RISK FACTORS ARE PRESENT: (A) A HISTORY OF SUBSTANCE USE DISORDER; (B) HIGH DOSE OR CUMULATIVE PRESCRIPTIONS THAT RESULT IN NINETY MORPHINE MILLIGRAM EQUIVALENTS OR HIGHER PER DAY; (C) CONCURRENT USE OF OPIOIDS AND BENZODIAZEPINE OR NONBENZODIAZEPINE SEDATIVE HYPNOTICS. § 2. This act shall take effect on the one hundred eightieth day after it shall have become a law. Effective immediately, the addition, amend- ment and/or repeal of any rule or regulation necessary for the implemen- tation of this act on its effective date are authorized to be made and completed by the commissioner of health on or before such effective date.
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.